Haemonetics(HAE)

Search documents
Haemonetics(HAE) - 2020 Q3 - Earnings Call Transcript
2020-02-04 19:18
Haemonetics Corporation (NYSE:HAE) Q3 2020 Earnings Conference Call February 4, 2020 8:00 AM ET Company Participants Olga Guyette - Director of Investor Relations Christopher Simon - President and Chief Executive Officer William Burke - Chief Financial Officer Conference Call Participants Anthony Petrone - Jefferies & Company, Inc. Lawrence Keusch - Raymond James Financial, Inc. David Turkaly - JMP Securities LLC Mason Austen - Morgan Stanley Michael Matson - Needham & Company, LLC Operator Ladies and gentl ...
Haemonetics(HAE) - 2020 Q2 - Quarterly Report
2019-11-01 20:06
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ☒ For the quarterly period ended: September 28, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-14041 HAEMONETICS CORPORATION (Exact name of registrant as specified in its charter) Massachusetts 04-2882273 (State or other jurisdiction of incorporation or organiza ...
Haemonetics(HAE) - 2020 Q2 - Earnings Call Transcript
2019-11-01 15:26
Haemonetics Corporation (NYSE:HAE) Q2 2020 Earnings Conference Call November 1, 2019 8:00 AM ET Company Participants Olga Guyette - Senior Manager, IR Chris Simon - CEO Bill Burke - CFO Conference Call Participants Anthony Petrone - Jefferies David Lewis - Morgan Stanley John Hsu - Raymond James Dave Turkaly - JMP Securities Larry Solow - CJS Securities Operator Ladies and gentlemen, thank you for standing by and welcome to the Haemonetics Second Quarter 2020 Conference Call. At this time, all participants ...
Haemonetics(HAE) - 2020 Q1 - Quarterly Report
2019-08-06 20:05
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ☒ For the quarterly period ended: June 29, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-14041 HAEMONETICS CORPORATION (Exact name of registrant as specified in its charter) Massachusetts 04-2882273 (State or other jurisdiction of incorporation or organization) ...
Haemonetics(HAE) - 2019 Q4 - Annual Report
2019-05-22 20:41
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Exact name of registrant as specified in its charter) Massachusetts 04-2882273 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 400 Wood Road, Braintree, Massachusetts 02184-9114 For the fiscal year ended March 30, 2019 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES E ...
Haemonetics(HAE) - 2019 Q4 - Earnings Call Transcript
2019-05-11 03:59
Haemonetics Corporation (NYSE:HAE) Q4 2019 Earnings Conference Call May 7, 2019 8:00 AM ET Company Participants Olga Vlasova – Investor Relations Chris Simon – Chief Executive Officer Bill burke – Chief Financial Officer Conference Call Participants David Lewis – Morgan Stanley Anthony Petrone – Jefferies Dave Turkaly – JMP Securities Larry Keusch – Raymond James Mike Petusky – Barrington Research Operator Good day, ladies and gentlemen, and welcome to the Fourth Quarter and Fiscal 2019 Haemonetics Conferen ...
Haemonetics(HAE) - 2019 Q3 - Quarterly Report
2019-02-05 21:02
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 For the quarter ended: December 29, 2018 Commission File Number: 001-14041 HAEMONETICS CORPORATION (Exact name of registrant as specified in its charter) Massachusetts (State or other jurisdiction of incorporation or organization) 04-2882273 (I.R.S. Employer Identification No.) FORM 10-Q Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 400 Wood Road, Braintree, MA 02184 Large accelerated filer þ Ac ...
Haemonetics(HAE) - 2019 Q3 - Earnings Call Transcript
2019-02-05 16:31
Haemonetics Corporation (NYSE:HAE) Q3 2019 Results Conference Call February 5, 2019 8:00 AM ET Company Participants Olga Vlasova - IR Chris Simon - CEO Bill Burke - CFO David Wilson - President, Global Plasma Conference Call Participants David Lewis - Morgan Stanley Anthony Petrone - Jefferies David Turkaly - JMP Securities Andrew Brackmann - William Blair Jim Sidoti - Sidoti and Company Operator Good day, ladies and gentlemen, and welcome to the Q3 2019 Haemonetics Corporation Earnings Conference Call. At ...